These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2824776)

  • 21. Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative.
    Wentland MP; Perni RB; Dorff PH; Rake JB
    J Med Chem; 1988 Sep; 31(9):1694-7. PubMed ID: 2842501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
    Furuhama K; Akahane K; Tawara K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of nephrotoxic effects of the new quinolone antibacterial agent levofloxacin in rabbits.
    Inage F; Kato M; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):395-7. PubMed ID: 1622439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gyrase inhibitor].
    Forth W
    Klin Wochenschr; 1985 Oct; 63(19):1036-9. PubMed ID: 2999503
    [No Abstract]   [Full Text] [Related]  

  • 25. Asymmetric synthesis and properties of the enantiomers of the antibacterial agent 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-1,4-dihydro-6- fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid hydrochloride.
    Rosen T; Chu DT; Lico IM; Fernandes PB; Shen L; Borodkin S; Pernet AG
    J Med Chem; 1988 Aug; 31(8):1586-90. PubMed ID: 3397996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7-Azetidinylquinolones as antibacterial agents. 3. Synthesis, properties and structure-activity relationships of the stereoisomers containing a 7-(3-amino-2-methyl-1-azetidinyl) moiety.
    Frigola J; Vañó D; Torrens A; Gómez-Gomar A; Ortega E; García-Granda S
    J Med Chem; 1995 Mar; 38(7):1203-15. PubMed ID: 7707323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antibacterial activities of optically active substituted 1,2-dihydro-6-oxo-6H-pyrrolo[3,2,1-ij]quinoline-5-carboxylic acids.
    Tsuji K; Tsubouchi H; Ishikawa H
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1678-82. PubMed ID: 8536340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute oral toxicity of the new quinolone antibacterial agent levofloxacin in mice, rats and monkeys.
    Kato M; Furuhama K; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):365-6. PubMed ID: 1622433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enantiomers of 1-ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid: preparation and biological activity.
    Culbertson TP; Domagala JM; Nichols JB; Priebe S; Skeean RW
    J Med Chem; 1987 Oct; 30(10):1711-5. PubMed ID: 2821256
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on structure of light degradation products of (-)-(S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihyd ro-7H- pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid (T-3761) in aqueous solution and solid state].
    Demachi K; Maeda H; Todo Y; Ojima K; Kokei T; Imaizumi H; Tai M; Nakajima Y; Narita H
    Yakugaku Zasshi; 1995 Sep; 115(9):716-31. PubMed ID: 8523266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproductive toxicity of ofloxacin.
    Takayama S; Watanabe T; Akiyama Y; Ohura K; Harada S; Matsuhashi K; Mochida K; Yamashita N
    Arzneimittelforschung; 1986 Aug; 36(8):1244-8. PubMed ID: 3465327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1229-36. PubMed ID: 18068979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids.
    Cecchetti V; Fravolini A; Fringuelli R; Mascellani G; Pagella P; Palmioli M; Segre G; Terni P
    J Med Chem; 1987 Mar; 30(3):465-73. PubMed ID: 3820216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on quinolone antibacterials. V. Synthesis and antibacterial activity of chiral 5-amino-7-(4-substituted-3-amino-1-pyrrolidinyl)-6- fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acids and derivatives.
    Yoshida T; Yamamoto Y; Orita H; Kakiuchi M; Takahashi Y; Itakura M; Kado N; Yasuda S; Kato H; Itoh Y
    Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1376-86. PubMed ID: 8706143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-six-week oral toxicity of the new quinolone antibacterial agent levofloxacin in rats and cynomolgus monkeys.
    Kato M; Furuhama K; Woolley AP; Ashby R; Fowler JS; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):367-73. PubMed ID: 1622434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LD50 value, phototoxicity and convulsion induction test of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acid hemihydrate in laboratory animals.
    Shimoda K; Akahane K; Nomura M; Kato M
    Arzneimittelforschung; 1996 Jun; 46(6):625-8. PubMed ID: 8767355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to the gyrase inhibitor group].
    Verho M; Dagrosa EE; Malerczyk V
    Infection; 1986; 14 Suppl 1():S47-53. PubMed ID: 3007366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis and Molecular Docking of 1-Cyclopropyl-6- Fluoro-4-Oxo-7-{4-[2-(4-Substituted-Phenyl)-2-(Substituted)-Ethyl] -1-Piperazinyl}-1,4-Dihydroquinoline-3-Carboxylic Acid as an Antimicrobial Agents.
    Patel MM; Patel LJ
    Curr Drug Discov Technol; 2017; 14(4):255-269. PubMed ID: 28240185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sub-inhibitory and post-antibiotic effects of an optically active isomer of ofloxacin.
    Tanaka M; Une T; Osada Y
    Arzneimittelforschung; 1989 Jul; 39(7):750-4. PubMed ID: 2506868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases.
    Hoshino K; Sato K; Akahane K; Yoshida A; Hayakawa I; Sato M; Une T; Osada Y
    Antimicrob Agents Chemother; 1991 Feb; 35(2):309-12. PubMed ID: 1850968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.